Nienke H van Teijlingen1, Angelique Hölzemer, Christian Körner, Wilfredo F García-Beltrán, Jamie L Schafer, Lena Fadda, Todd J Suscovich, Christian Brander, Mary Carrington, David T Evans, Debbie van Baarle, Marcus Altfeld. 1. aRagon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA bExperimental Immunology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands cDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston dDivision of Microbiology, New England Primate Research Center, Southborough, Massachusetts, USA eIrsicaixa AIDS Research Institute - HIVACAT, Autonomous University of Barcelona, Badalona and Institució Catalana de Recerca i Estudis Avancats (ICREA), Barcelona, Spain fCancer and Inflammation Program, Laboratory of Experimental Immunology, SAIC Frederick, Inc., Frederick National Laboratories for Cancer Research, Frederick, Maryland gDepartment of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin, USA hLaboratory for Translational Immunology, University Medical Center Utrecht, Utrecht iCenter for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands jHeinrich-Pette-Institut, Leibniz Institute for Experimental Virology, Hamburg, Germany. *Nienke H. van Teijlingen and Angelique Hölzemer have contributed equally to the writing of the manuscript.
Abstract
OBJECTIVE: The aim of this study was to assess the consequence of sequence variations in HLA-C03:04-presented HIV-1 p24 Gag epitopes on binding of the inhibitory natural killer (NK) cell receptor KIR2DL2 to HLA-C03:04. DESIGN: HIV-1 may possibly evade recognition by KIR+ NK cells through selection of sequence variants that interfere with the interactions of inhibitory killer cell immunoglobulin-like receptors (KIRs) and their target ligands on HIV-1 infected cells. KIR2DL2 is an inhibitory NK cell receptor that binds to a family of HLA-C ligands. Here, we investigated whether HIV-1 encodes for HLA-C03:04-restricted epitopes that alter KIR2DL2 binding. METHODS: Tapasin-deficient 721.220 cells expressing HLA-C03:04 were pulsed with overlapping peptides (10mers overlapped by nine amino acids, spanning the entire HIV-1 p24 Gag sequence) to identify peptides that stabilized HLA-C expression. The impact that sequence variation in HLA-C03:04-binding HIV-1 epitopes has on KIR2DL2 binding and KIR2DL2+ NK cell function was determined using KIR2DL2-Fc constructs and NK cell degranulation assays. RESULTS: Several novel HLA-C03:04 binding epitopes were identified within the HIV-1 p24 Gag consensus sequence. Three of these consensus sequence peptides (Gag144-152, Gag163-171 and Gag295-304) enabled binding of KIR2DL2 to HLA-C03:04 and resulted in inhibition of KIR2DL2+ primary NK cells. Furthermore, naturally occurring minor variants of epitope Gag295-304 enhanced KIR2DL2 binding to HLA-C03:04. CONCLUSION: Our data show that naturally occurring sequence variations within HLA-C03:04-restricted HIV-1 p24 Gag epitopes can have a significant impact on the binding of inhibitory KIR receptors and primary NK cell function.
OBJECTIVE: The aim of this study was to assess the consequence of sequence variations in HLA-C03:04-presented HIV-1p24Gag epitopes on binding of the inhibitory natural killer (NK) cell receptor KIR2DL2 to HLA-C03:04. DESIGN:HIV-1 may possibly evade recognition by KIR+ NK cells through selection of sequence variants that interfere with the interactions of inhibitory killer cell immunoglobulin-like receptors (KIRs) and their target ligands on HIV-1 infected cells. KIR2DL2 is an inhibitory NK cell receptor that binds to a family of HLA-C ligands. Here, we investigated whether HIV-1 encodes for HLA-C03:04-restricted epitopes that alter KIR2DL2 binding. METHODS:Tapasin-deficient 721.220 cells expressing HLA-C03:04 were pulsed with overlapping peptides (10mers overlapped by nine amino acids, spanning the entire HIV-1p24Gag sequence) to identify peptides that stabilized HLA-C expression. The impact that sequence variation in HLA-C03:04-binding HIV-1 epitopes has on KIR2DL2 binding and KIR2DL2+ NK cell function was determined using KIR2DL2-Fc constructs and NK cell degranulation assays. RESULTS: Several novel HLA-C03:04 binding epitopes were identified within the HIV-1p24Gag consensus sequence. Three of these consensus sequence peptides (Gag144-152, Gag163-171 and Gag295-304) enabled binding of KIR2DL2 to HLA-C03:04 and resulted in inhibition of KIR2DL2+ primary NK cells. Furthermore, naturally occurring minor variants of epitope Gag295-304 enhanced KIR2DL2 binding to HLA-C03:04. CONCLUSION: Our data show that naturally occurring sequence variations within HLA-C03:04-restricted HIV-1p24Gag epitopes can have a significant impact on the binding of inhibitory KIR receptors and primary NK cell function.
Authors: Agatha M Masemola; Tumelo N Mashishi; Greg Khoury; Helba Bredell; Maria Paximadis; Tiyani Mathebula; Debra Barkhan; Adrian Puren; Efthyia Vardas; Mark Colvin; Lynn Zijenah; David Katzenstein; Rosemary Musonda; Susan Allen; Newton Kumwenda; Taha Taha; Glenda Gray; James McIntyre; Salim Abdool Karim; Haynes W Sheppard; Clive M Gray Journal: J Immunol Date: 2004-10-01 Impact factor: 5.422
Authors: R Kaul; T Dong; F A Plummer; J Kimani; T Rostron; P Kiama; E Njagi; E Irungu; B Farah; J Oyugi; R Chakraborty; K S MacDonald; J J Bwayo; A McMichael; S L Rowland-Jones Journal: J Clin Invest Date: 2001-05 Impact factor: 14.808
Authors: Maureen P Martin; Xiaojiang Gao; Jeong-Hee Lee; George W Nelson; Roger Detels; James J Goedert; Susan Buchbinder; Keith Hoots; David Vlahov; John Trowsdale; Michael Wilson; Stephen J O'Brien; Mary Carrington Journal: Nat Genet Date: 2002-07-22 Impact factor: 38.330
Authors: Richard Apps; Ying Qi; Jonathan M Carlson; Haoyan Chen; Xiaojiang Gao; Rasmi Thomas; Yuko Yuki; Greg Q Del Prete; Philip Goulder; Zabrina L Brumme; Chanson J Brumme; Mina John; Simon Mallal; George Nelson; Ronald Bosch; David Heckerman; Judy L Stein; Kelly A Soderberg; M Anthony Moody; Thomas N Denny; Xue Zeng; Jingyuan Fang; Ashley Moffett; Jeffrey D Lifson; James J Goedert; Susan Buchbinder; Gregory D Kirk; Jacques Fellay; Paul McLaren; Steven G Deeks; Florencia Pereyra; Bruce Walker; Nelson L Michael; Amy Weintrob; Steven Wolinsky; Wilson Liao; Mary Carrington Journal: Science Date: 2013-04-05 Impact factor: 47.728
Authors: Thomas van Stigt Thans; Janet I Akko; Annika Niehrs; Wilfredo F Garcia-Beltran; Laura Richert; Christina M Stürzel; Christopher T Ford; Hui Li; Christina Ochsenbauer; John C Kappes; Beatrice H Hahn; Frank Kirchhoff; Glòria Martrus; Daniel Sauter; Marcus Altfeld; Angelique Hölzemer Journal: J Virol Date: 2019-09-30 Impact factor: 5.103
Authors: A Wahid Ansari; Fareed Ahmad; Dirk Meyer-Olson; Adeeba Kamarulzaman; Roland Jacobs; Reinhold E Schmidt Journal: Cell Mol Life Sci Date: 2015-05-05 Impact factor: 9.207
Authors: Maja C Ziegler; Kewreshini Naidoo; Anais Chapel; Sindiswa Nkotwana; Jaclyn Mann; Zenele Mncube; Nasreen Ismael; Philip Goulder; Thumbi Ndung'u; Marcus Altfeld; Christina F Thobakgale Journal: AIDS Date: 2021-01-01 Impact factor: 4.632